Bausch + Lomb price target lowered to $18 from $19 at Stifel

Stifel analyst Thomas Stephan lowered the firm’s price target on Bausch + Lomb (BLCO) to $18 from $19 and keeps a Hold rating on the shares. The firm’s contact lens survey diligence suggests relatively static “share” among the four major manufacturers in 2025, says the analyst, who adds that SiHy Dailies have been “highly-impressive” and alone can likely contribute 1 point of total B+L revenue growth in 2025. However, the firm lowered estimates for both Alcon (ALC) and B+L, due primarily to foreign exchange, along with a softer 2025 Xiidra outlook for B+L.